162 related articles for article (PubMed ID: 29398153)
1. Impact of pemetrexed on intracranial disease control and radiation necrosis in patients with brain metastases from non-small cell lung cancer receiving stereotactic radiation.
Cagney DN; Martin AM; Catalano PJ; Reitman ZJ; Mezochow GA; Lee EQ; Wen PY; Weiss SE; Brown PD; Ahluwalia MS; Arvold ND; Tanguturi SK; Haas-Kogan DA; Alexander BM; Redig AJ; Aizer AA
Radiother Oncol; 2018 Mar; 126(3):511-518. PubMed ID: 29398153
[TBL] [Abstract][Full Text] [Related]
2. Expanding the Spectrum of Radiation Necrosis After Stereotactic Radiosurgery (SRS) for Intracranial Metastases From Lung Cancer: A Retrospective Review.
Sharma A; Mountjoy LJ; Butterfield RJ; Zhang N; Ross HJ; Schild SE; Sio TT; Daniels TB; Paripati HR; Mrugala MM; Vora SA; Patel NP; Zimmerman RS; Ashman JB; Porter AB
Am J Clin Oncol; 2020 Feb; 43(2):128-132. PubMed ID: 31764021
[TBL] [Abstract][Full Text] [Related]
3. Frontline Systemic Therapy With Pemetrexed-Platinum in Nonsquamous Non-Small-Cell Lung Cancer With Asymptomatic Brain Metastases.
Alsidawi S; Chaudhary R; Karim NA
Am J Ther; 2017; 24(2):e111-e120. PubMed ID: 25153672
[TBL] [Abstract][Full Text] [Related]
4. Phase II Study of High-Dose Pemetrexed Plus Cisplatin as First-Line Chemotherapy In the Treatment of Patients with Brain Metastases from Lung Adenocarcinoma.
He Q; Wang Y; Zou P; Wang Y; Xiu C; Zhang H; Chi N; Zou H; Xu J; Zhou S; Tao R
World Neurosurg; 2017 Mar; 99():758-762. PubMed ID: 27060518
[TBL] [Abstract][Full Text] [Related]
5. Ipilimumab and Stereotactic Radiosurgery Versus Stereotactic Radiosurgery Alone for Newly Diagnosed Melanoma Brain Metastases.
Patel KR; Shoukat S; Oliver DE; Chowdhary M; Rizzo M; Lawson DH; Khosa F; Liu Y; Khan MK
Am J Clin Oncol; 2017 Oct; 40(5):444-450. PubMed ID: 26017484
[TBL] [Abstract][Full Text] [Related]
6. Association Between Radiation Necrosis and Tumor Biology After Stereotactic Radiosurgery for Brain Metastasis.
Miller JA; Bennett EE; Xiao R; Kotecha R; Chao ST; Vogelbaum MA; Barnett GH; Angelov L; Murphy ES; Yu JS; Ahluwalia MS; Suh JH; Mohammadi AM
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1060-1069. PubMed ID: 27742540
[TBL] [Abstract][Full Text] [Related]
7. Does immunotherapy increase the rate of radiation necrosis after radiosurgical treatment of brain metastases?
Colaco RJ; Martin P; Kluger HM; Yu JB; Chiang VL
J Neurosurg; 2016 Jul; 125(1):17-23. PubMed ID: 26544782
[TBL] [Abstract][Full Text] [Related]
8. Impact of Systemic Therapy Type and Timing on Intracranial Tumor Control in Patients with Brain Metastasis from Non-Small-Cell Lung Cancer Treated With Stereotactic Radiosurgery.
Singh SA; McDermott DM; Mattes MD
World Neurosurg; 2020 Dec; 144():e813-e823. PubMed ID: 32956881
[TBL] [Abstract][Full Text] [Related]
9. Alectinib induced CNS radiation necrosis in an ALK+NSCLC patient with a remote (7 years) history of brain radiation.
Ou SH; Weitz M; Jalas JR; Kelly DF; Wong V; Azada MC; Quines O; Klempner SJ
Lung Cancer; 2016 Jun; 96():15-8. PubMed ID: 27133743
[TBL] [Abstract][Full Text] [Related]
10. First assessment of whole-brain radiation therapy combined with pemetrexed-based chemotherapy in non-small-cell lung carcinoma: data on safety and efficacy.
Chargari C; Pacaut C; Le Moulec S; Moriceau G; Moussaid Y; Rivoirard R; Dulou R; Jacob J; Guy JB; Bauduceau O; Ceccaldi B; Védrine L; Fournel P; Magné N
Anticancer Drugs; 2013 Aug; 24(7):736-42. PubMed ID: 23542752
[TBL] [Abstract][Full Text] [Related]
11. BRAF inhibitor and stereotactic radiosurgery is associated with an increased risk of radiation necrosis.
Patel KR; Chowdhary M; Switchenko JM; Kudchadkar R; Lawson DH; Cassidy RJ; Prabhu RS; Khan MK
Melanoma Res; 2016 Aug; 26(4):387-94. PubMed ID: 27223498
[TBL] [Abstract][Full Text] [Related]
12. Surgery of enlarging lesions after stereotactic radiosurgery for brain metastases in patients with non-small cell lung cancer with oncogenic driver mutations frequently reveals radiation necrosis: case series and review.
Zhou F; Jiang L; Sun X; Wang Z; Feng J; Liu M; Ma Z
APMIS; 2024 Jun; 132(6):375-381. PubMed ID: 38466886
[TBL] [Abstract][Full Text] [Related]
13. Response to afatinib in treatment-naïve patients with advanced mutant epidermal growth factor receptor lung adenocarcinoma with brain metastases.
Li SH; Liu CY; Hsu PC; Fang YF; Wang CC; Kao KC; Tseng LC; Yang CT
Expert Rev Anticancer Ther; 2018 Jan; 18(1):81-89. PubMed ID: 29172778
[TBL] [Abstract][Full Text] [Related]
14. Capecitabine and stereotactic radiation in the management of breast cancer brain metastases.
Mills MN; Naz A; Thawani C; Walker C; Figura NB; Kushchayev S; Oliver DE; Etame AB; Yu HM; Robinson TJ; Liu JKC; Vogelbaum MA; Forsyth PA; Czerniecki BJ; Soliman HH; Han HS; Ahmed KA
BMC Cancer; 2021 May; 21(1):552. PubMed ID: 33992087
[TBL] [Abstract][Full Text] [Related]
15. Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases.
Kohutek ZA; Yamada Y; Chan TA; Brennan CW; Tabar V; Gutin PH; Yang TJ; Rosenblum MK; Ballangrud Å; Young RJ; Zhang Z; Beal K
J Neurooncol; 2015 Oct; 125(1):149-56. PubMed ID: 26307446
[TBL] [Abstract][Full Text] [Related]
16. The impact of tumor biology on survival and response to radiation therapy among patients with non-small cell lung cancer brain metastases.
Miller JA; Kotecha R; Ahluwalia MS; Mohammadi AM; Suh JH; Barnett GH; Murphy ES; Vogelbaum MA; Angelov L; Chao ST
Pract Radiat Oncol; 2017; 7(4):e263-e273. PubMed ID: 28254368
[TBL] [Abstract][Full Text] [Related]
17. Activity of Pemetrexed on brain metastases from Non-Small Cell Lung Cancer.
Bearz A; Garassino I; Tiseo M; Caffo O; Soto-Parra H; Boccalon M; Talamini R; Santoro A; Bartolotti M; Murgia V; Berretta M; Tirelli U
Lung Cancer; 2010 May; 68(2):264-8. PubMed ID: 19632738
[TBL] [Abstract][Full Text] [Related]
18. Hypofractionated Stereotactic Radiation Therapy to the Resection Bed for Intracranial Metastases.
Keller A; Doré M; Cebula H; Thillays F; Proust F; Darié I; Martin SA; Delpon G; Lefebvre F; Noël G; Antoni D
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1179-1189. PubMed ID: 28974415
[TBL] [Abstract][Full Text] [Related]
19. Reenlargement of radiation necrosis after stereotactic radiotherapy for brain metastasis from lung cancer during bevacizumab treatment.
Furuuchi K; Nishiyama A; Yoshioka H; Yokoyama T; Ishida T
Respir Investig; 2017 Mar; 55(2):184-187. PubMed ID: 28274537
[TBL] [Abstract][Full Text] [Related]
20. Severe Radiation Necrosis Refractory to Surgical Resection in Patients with Melanoma and Brain Metastases Managed with Ipilimumab/Nivolumab and Brain-Directed Stereotactic Radiation Therapy.
Shi DD; Arnaout O; Bi WL; Buchbinder EI; Cagney DN; Insco ML; Liu D; Schoenfeld JD; Aizer AA
World Neurosurg; 2020 Jul; 139():226-231. PubMed ID: 32330622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]